These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 19350459)

  • 1. Oncology biomarkers--second annual GTCbio conference. Biomarkers for disease detection and therapeutics monitoring. 19-20 January 2009, Miami, FL, USA.
    Scholler N
    IDrugs; 2009 Apr; 12(4):207-10. PubMed ID: 19350459
    [No Abstract]   [Full Text] [Related]  

  • 2. Giving Up on Precision Oncology? Not So Fast!
    Warner JL
    Clin Transl Sci; 2017 May; 10(3):128-129. PubMed ID: 28146309
    [No Abstract]   [Full Text] [Related]  

  • 3. Transport Barriers and Oncophysics in Cancer Treatment.
    Nizzero S; Ziemys A; Ferrari M
    Trends Cancer; 2018 Apr; 4(4):277-280. PubMed ID: 29606312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delivering on the promise of precision cancer medicine.
    Berger MF; Van Allen EM
    Genome Med; 2016 Oct; 8(1):110. PubMed ID: 27782852
    [No Abstract]   [Full Text] [Related]  

  • 5. JAMA Oncology Patient Page. The Evolution of a Cancer.
    West HJ; Jin JO
    JAMA Oncol; 2015 Sep; 1(6):850. PubMed ID: 26247697
    [No Abstract]   [Full Text] [Related]  

  • 6. Personalized Medicine: Genomics Trials in Oncology.
    Hayes DF; Schott AF
    Trans Am Clin Climatol Assoc; 2015; 126():133-43. PubMed ID: 26330667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting Biophysical Cues: a Niche Approach to Study, Diagnose, and Treat Cancer.
    Zhang SX; Liu L; Zhao W
    Trends Cancer; 2018 Apr; 4(4):268-271. PubMed ID: 29606309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic drug monitoring in oncology: does it have a future?
    McMahon G; O'Connor R
    Bioanalysis; 2009 Jun; 1(3):507-11. PubMed ID: 21083145
    [No Abstract]   [Full Text] [Related]  

  • 9. Emerging trends in biomarker discovery: Ease of prognosis and prediction in cancer.
    Sharma AK
    Semin Cancer Biol; 2018 Oct; 52(Pt 1):iii-iv. PubMed ID: 29857038
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical cancer advances 2015: Annual report on progress against cancer from the American Society of Clinical Oncology.
    Masters GA; Krilov L; Bailey HH; Brose MS; Burstein H; Diller LR; Dizon DS; Fine HA; Kalemkerian GP; Moasser M; Neuss MN; O'Day SJ; Odenike O; Ryan CJ; Schilsky RL; Schwartz GK; Venook AP; Wong SL; Patel JD
    J Clin Oncol; 2015 Mar; 33(7):786-809. PubMed ID: 25605863
    [No Abstract]   [Full Text] [Related]  

  • 11. Therapeutic Drug Monitoring in Oncology.
    Wilkinson DS
    Ther Drug Monit; 2019 Oct; 41(5):551-552. PubMed ID: 31318845
    [No Abstract]   [Full Text] [Related]  

  • 12. The translational potential of circulating tumour DNA in oncology.
    Patel KM; Tsui DW
    Clin Biochem; 2015 Oct; 48(15):957-61. PubMed ID: 25889059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abstracts of the 2007 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics: Discovery, Biology, and Clinical Applications. October 22-26, 2007. San Francisco, California, USA.
    Mol Cancer Ther; 2007 Dec; 6(12 Pt 2):3331s-704s. PubMed ID: 18300399
    [No Abstract]   [Full Text] [Related]  

  • 14. Validation of analytic methods for biomarkers used in drug development.
    Chau CH; Rixe O; McLeod H; Figg WD
    Clin Cancer Res; 2008 Oct; 14(19):5967-76. PubMed ID: 18829475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic testing in cancer therapeutics.
    Ezzeldin HH; Diasio RB
    Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4137-41. PubMed ID: 16857783
    [No Abstract]   [Full Text] [Related]  

  • 16. National Cancer Institute's Precision Medicine Initiatives for the new National Clinical Trials Network.
    Abrams J; Conley B; Mooney M; Zwiebel J; Chen A; Welch JJ; Takebe N; Malik S; McShane L; Korn E; Williams M; Staudt L; Doroshow J
    Am Soc Clin Oncol Educ Book; 2014; ():71-6. PubMed ID: 24857062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A urologic oncology roundtable discussion: the role of disease monitoring in treatment decision-making for patients with metastatic castration-resistant prostate cancer.
    Shore ND; Concepcion R; Barocas DA
    Hosp Pract (1995); 2013; 41(4):78-80. PubMed ID: 24145592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First advanced course on biomarkers in molecular and immuno-oncology in the Middle East.
    Moujaess E; Khoury M; Zouein J; Eid JB; Mohty R; Kourie HR
    Future Oncol; 2021 Aug; 17(22):2831-2834. PubMed ID: 34148366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacometrics and systems biology in oncology: is there an intersection?
    Kloft C
    Int J Clin Pharmacol Ther; 2013 Jan; 51(1):89-90. PubMed ID: 23260011
    [No Abstract]   [Full Text] [Related]  

  • 20. The arrival of predictive biomarkers for monitoring therapy response to natural compounds in cancer drug discovery.
    El Bairi K; Atanasov AG; Amrani M; Afqir S
    Biomed Pharmacother; 2019 Jan; 109():2492-2498. PubMed ID: 30551510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.